TECH
Price
$54.89
Change
-$3.49 (-5.98%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
8.67B
27 days until earnings call
TRDA
Price
$8.02
Change
-$0.78 (-8.86%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
330.83M
35 days until earnings call
Ad is loading...

TECH vs TRDA

Header iconTECH vs TRDA Comparison
Open Charts TECH vs TRDABanner chart's image
Bio-Techne
Price$54.89
Change-$3.49 (-5.98%)
Volume$35.01K
Capitalization8.67B
Entrada Therapeutics
Price$8.02
Change-$0.78 (-8.86%)
Volume$6.17K
Capitalization330.83M
TECH vs TRDA Comparison Chart
Loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TECH vs. TRDA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECH is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (TECH: $58.38 vs. TRDA: $8.80)
Brand notoriety: TECH and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TECH: 81% vs. TRDA: 148%
Market capitalization -- TECH: $8.67B vs. TRDA: $300.76M
TECH [@Biotechnology] is valued at $8.67B. TRDA’s [@Biotechnology] market capitalization is $300.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 2 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • TECH’s FA Score: 2 green, 3 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TECH is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TECH’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • TECH’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TECH is a better buy in the short-term than TRDA.

Price Growth

TECH (@Biotechnology) experienced а -1.68% price change this week, while TRDA (@Biotechnology) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

TECH is expected to report earnings on Apr 30, 2025.

TRDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($8.67B) has a higher market cap than TRDA($331M). TECH has higher P/E ratio than TRDA: TECH (55.99) vs TRDA (5.24). TECH YTD gains are higher at: -18.853 vs. TRDA (-49.104). TECH has higher annual earnings (EBITDA): 307M vs. TRDA (50.8M). TRDA has more cash in the bank: 420M vs. TECH (178M). TRDA has less debt than TECH: TRDA (59.2M) vs TECH (395M). TECH has higher revenues than TRDA: TECH (1.2B) vs TRDA (211M).
TECHTRDATECH / TRDA
Capitalization8.67B331M2,621%
EBITDA307M50.8M604%
Gain YTD-18.853-49.10438%
P/E Ratio55.995.241,069%
Revenue1.2B211M567%
Total Cash178M420M42%
Total Debt395M59.2M667%
FUNDAMENTALS RATINGS
TECH: Fundamental Ratings
TECH
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TECHTRDA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
72%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMGJX6.88N/A
N/A
Principal MidCap Growth J
MSQLX10.33N/A
N/A
Morgan Stanley Inst International Eq L
HNRGX28.96N/A
N/A
Hennessy Energy Transition Investor
WWNPX153.43N/A
N/A
Kinetics Paradigm No Load
JEMWX31.58N/A
N/A
JPMorgan Emerging Markets Equity R6

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+0.46%
CRNX - TRDA
49%
Loosely correlated
+2.51%
RXRX - TRDA
49%
Loosely correlated
+3.83%
ATXS - TRDA
48%
Loosely correlated
+2.22%
IMNM - TRDA
45%
Loosely correlated
+7.19%
ARCT - TRDA
45%
Loosely correlated
+8.17%
More